Regarding CD8+ αβ T cells, the proportion of tumor antigen-specific CD8+ αβ T cells in tumor-infiltrating T lymphocytes (TILs) is only 10% and it is difficult to expand a large number of functional tumor antigen-specific CD8+ T cells for adoptive immunotherapy (45). Here, CD8A is linked to neoplasm.